New Cryoprobe System with Powerful Heating Features and Its Performance Tests on Biomaterials

J Liu,YX Zhou,TH Yu,L Gui,ZS Deng,YG Lv

DOI: https://doi.org/10.1115/imece2003-41357

2003-01-01

Abstract:Cryosurgery is a clinical therapy aiming at destroying the target of diseased tissues through a controlled deep freezing and subsequent rewarming [1,2]. Applications of this treatment are quite wide in skin cancers, glaucoma, lung tumor etc. [3]-[10]. In contrast to the freezing therapy, heating of tumors has also long been proved to be an effective way of selectively killing the cells of cancerous tissues [11]-[13]. Clinical tests showed that heating the tumor to above a critical minimum temperature such as 42–43 °C for an extended period could effectively destroy the target. It was recently realized that freezing immediately followed by a rapid and strong heating of the target tissues would significantly improve the treatment effect [14]-[16]. Therefore, an apparatus thus developed will be of great importance in cancer clinics. But until now, most of the currently available cryoprobe systems are only capable of performing a single freezing function, in which the treated tissue is often let to naturally re-warm by simply switching off the apparatus. The first one and only commercially available cryoprobe system aiming at both freezing and heating therapy is perhaps Endocare Corporation’s Ar-He Cryoprobe system [14]. However, the highest tissue temperature for this system to achieve is about 0–20 °C [17], which is not high enough to thermally destroy the target tissues. Presently, there is a strong lack of freezing applicators with powerful heating functions for hyperthermia purposes. Without strong enough heating, tumors may still have a chance to regenerate. This is perhaps one of the critical reasons to impede the widespread of cryosurgery in destroying pathological tissues.